Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 3/2002

01-09-2002 | Case Report

Bacteremic and leukopenic pneumococcal pneumonia: successful treatment with antibiotics, pulse steroid, and continuous hemodiafiltration

Authors: Toshinobu Yokoyama, Teruo Sakamoto, Norihiko Shida, Toshifumi Shimada, Nobuo Kaku, Hisamichi Aizawa, Kotaro Oizumi

Published in: Journal of Infection and Chemotherapy | Issue 3/2002

Login to get access
Metadata
Title
Bacteremic and leukopenic pneumococcal pneumonia: successful treatment with antibiotics, pulse steroid, and continuous hemodiafiltration
Authors
Toshinobu Yokoyama
Teruo Sakamoto
Norihiko Shida
Toshifumi Shimada
Nobuo Kaku
Hisamichi Aizawa
Kotaro Oizumi
Publication date
01-09-2002
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 3/2002
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-002-0173-y

Other articles of this Issue 3/2002

Journal of Infection and Chemotherapy 3/2002 Go to the issue

Committee Report: Clinical Trial Protocol for a New Antimicrobial Agent for the Treatment of Respiratory Tract Infections

Respiratory Tract Committee, Protocol Composition Committee, Clinical Trial Committee, Japanese Society of Chemotherapy

Case Report

A patient with adult Still’s disease with an increased Chlamydia pneumoniae antibody titer

Review Article

Development and use of palivizumab (Synagis): a passive immunoprophylactic agent for RSV

Original Article

Analysis of physical and laboratory findings in nontyphoidal salmonellosis

Note

Time interval between the onset of type A influenza and consultation at the outpatient clinic in a community hospital: 1999–2000 epidemic

Original Article

Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits